Introduction {#Sec1}
============

Many lesions in the kidney are discovered by coincidence because of increased use of modern imaging modalities such as ultrasonography (US), computerised tomography (CT) and magnetic resonance imaging (MRI) \[[@CR1]--[@CR3]\]. Renal cysts are rare in children (0.1 %--0.45 %) and common in adults, with approximately 50 % of individuals over 50 years of age having renal cysts \[[@CR2], [@CR4]\]. Renal cysts are most often simple and asymptomatic. Distinguishing simple renal cysts from solid tumours in the kidney does not represent a diagnostic challenge. Complex renal cysts, on the other hand, are still a clinical problem \[[@CR2], [@CR5], [@CR6]\]. The most important element in the diagnostic categorisation of complex renal cysts is to be able to differentiate between benign and possibly malignant lesions---in other words to identify (1) which lesions require surgical intervention, (2) which can be safely followed by imaging and (3) which are unequivocally benign and need no surgical intervention or imaging follow-up.

The Bosniak classification is a diagnostic system for the differentiation of cystic renal lesions in the kidney using CT. It was introduced in 1986 and has been updated several times, most recently in 2005 \[[@CR5]\]. The classification system is based on several morphological changes in renal cysts: septa formation, wall thickening including nodal components, calcification in the wall and/or septa, hyperdense cystic content and contrast enhancement after intravenous contrast injection. The cystic lesions in the kidney are divided into four categories using CT. Bosniak category I and II lesions are predicted to be benign, category III potential malignant and IV predominantly malignant. Category IIF (BIIF) has subsequently been introduced for those cysts that cannot be clearly categorised as category II or III and therefore need follow-up imaging. Since 1993, when M.A. Bosniak added the category IIF, few studies have been published regarding this subject and only three series with more than ten BIIF lesions \[[@CR6]--[@CR13]\].

The aim of this study was to investigate the usefulness of Bosniak category IIF and evaluate the clinical outcome of moderately complex renal cysts compared to published data in the literature.

Materials and methods {#Sec2}
=====================

The regional ethics committee approved the study, project ID: S-20090137. In a 7-year period (January 2003-December 2009) radiological reports from 8,402 CT examinations of the kidney were analysed retrospectively by one radiologist with 5 years\' experience. All patients with complex renal cysts and normal renal function (estimated creatinine clearance \>60 ml/min/1.74 m2) diagnosed on multiphase contrast-enhanced CT and with ≥2-year follow-up were included in the study (*n* = 550). The lesions on the CT examinations were reclassified according to the Bosniak classification by two experienced uroradiologists with 5 years and 20 years of experience, respectively. The image analysis was performed in consensus. All patients were recruited from one institution and were examined with the same follow-up protocol and with the same CT scanner and CT protocol. The complexity of each lesion was assessed according to the Bosniak classification on the basis of the number and appearance of the septa, wall thickness, hyperdense cystic content, interface with the kidney parenchyma, presence and amount of calcification, and contrast enhancement characteristics. Lesion size was measured in two dimensions on the axial image. Follow-up examinations were evaluated for any interval change. Estimated radiation exposure for each CT scan, represented in mSv, was calculated with the conversion factor, 0.017 mSv/mGy × cm × the dose length product (DLP).

In this study only Bosniak category IIF cysts were included. From the total number of BIIF lesions we selected patients with ≥2 years of follow-up. This group was divided into (1) stable BIIF lesions with follow-up of 2--5 years, (2) stable BIIF lesions with follow-up of ≥5 years and (3) those BIIF lesions that progressed in complexity and therefore were upgraded to BIII. None of the patients had more than one BIIF cyst.

A literature search was performed with Entrez PubMed for the period 1986--2012 (key words: Bosniak classification, renal cysts, renal cell carcinoma, renal cancer, RCC, computed tomography, CT, magnetic resonance imaging, MRI, US, contrast-enhanced ultrasonography, CEUS). Only English-language publications were included.

Imaging {#Sec3}
=======

The patient was assessed while supine using a CT scanner (SOMATOM Sensation 4, Siemens Medical Solutions, Germany). Patients were orally administrated 500 ml water 30 min prior to the examination. The scan range field of view (FoV), including only the kidneys and adrenal glands, was at the skin level. Before contrast injection an unenhanced CT was performed. A bolus of 90 ml iodine contrast (Visipaque® 320 mg/ml, Iodixanol, GE Healthcare) was injected intravenously followed by a 20 ml saline solution (0.9 % NaCl) flush with an injection rate of 4 ml/s. To obtain correct and reproducible contrast phases, the arterial contrast concentration was monitored with the region of interest (ROI) in the abdominal aorta at diaphragm level with a trigger level at 100 Hounsfield units (HU). Corticomedullary and nephrographic phase images were performed 10 and 65 s after the trigger. Scanning parameters were kept the same: 2.5 mm collimation × 4; table speed 12.5 mm/s (pitch, 1.25 mm); 165 mAs; 120 kV; 512 × 512 matrix. All images were reconstructed with a soft algorithm and WW/WL at 400/40 in transversal, coronal and sagittal orientation in 3-mm slice thickness with an overlap of 2 mm.

Results {#Sec4}
=======

The flowchart (Fig. [1](#Fig1){ref-type="fig"}) shows that of 550 complex renal cysts ≥ Bosniak category II, 44 patients had moderately complex renal cysts categorised as Bosniak IIF. For those BIIF lesions with a follow-up period ≥2 years (*n* = 32), the mean follow-up was 1,393 days (735--4,046 days). Sixteen per cent (5/32) were upgraded to category BIII within a mean follow-up period of 3 years (735--1,539 days). Six patients had no follow-up CT and were excluded: two patients died from other disease, two patients had severe comorbidity, one patient did not wish to participate in the follow-up programme, and one patient, 14 years of age, was lost to follow-up. Mean radiation dose was 12.8 mSv (7--30 mSv).Fig. 1Flowchart

In the five patients who were upgraded, three underwent surgery, and the pathology of these three lesions showed papillary carcinoma, clear cell renal carcinoma (Figs. [2](#Fig2){ref-type="fig"} and [3](#Fig3){ref-type="fig"}) and chronic inflammation with no malignancy, respectively. Due to comorbidity, the other two patients were not treated surgically; however at CT follow-up they did not show any further progression. Thirty-one per cent (10/32) of the lesions with mean follow-up periods \>5 years (mean 1923 days, range 1229--4046 days) were stable during follow-up, suggesting benignity (Fig. [4](#Fig4){ref-type="fig"}). Table [1](#Tab1){ref-type="table"} presents a detailed summery of the cohort. Figures [5](#Fig5){ref-type="fig"}, [6](#Fig6){ref-type="fig"}, [7](#Fig7){ref-type="fig"}, [8](#Fig8){ref-type="fig"}, [9](#Fig9){ref-type="fig"} and [10](#Fig10){ref-type="fig"} show four different BIIF lesions from the cohort and examples of BII and BIII cysts.Fig. 2Transversal baseline **a** corticomedullary phase CT image of a 61-year-old male with a moderately complex renal cystic lesion showing minimal thickening of the wall and septa without enhancement (arrow), interpreted as BIIF. Transversal **b** corticomedullary phase and **c** nephrographic phase CT images after 4-year follow-up: The lesion progressed in complexity with enlargement of the intrarenal component leading to up-classification to BIII. Pathological diagnosis was clear cell renal carcinoma, primarily located focally in the septumFig. 3Transversal baseline **a** corticomedullary phase CT image of a 61-year-old male with a moderately complex renal cystic lesion showing minimal thickening and calcification of the wall without enhancement (*arrow*), interpreted as BIIF. After 2-year follow-up the lesion progressed in complexity with a more irregular wall and was up-classified to BIII. Transversal **b** corticomedullary phase and **c** nephrographic phase images showing slightly thickened, partially calcified wall without measurable contrast enhancement (*arrowhead*) after the lesion had been up-classified. Pathologic diagnosis was papillary renal cell carcinomaFig. 4Corticomedullary phase CT images in **a** transversal plane and **b** coronal plane of a 68-year-old male with a moderately complex renal cystic lesion (*arrow*) showing hairline-thin smooth septa and wall with minimal thickening and calcification of septa without measurable contrast enhancement (*arrowhead*). There was no progression of the lesion after 5-year follow-upTable 1Summary of the cohortTotalBIIFBIIFBIIFBIIIFollow-up ≥2 yearsFollow-up 2--5 yearsFollow-up \>5 yearsBIIF upgraded during follow-upNumber of lesions with follow-up ≥2 years443217105Sex (male/female)26/1817/158/95/54/1Mean age in years66.6465.3164.5966.1066.20(Range)(14--87)(40--87)(40--87)(46--83)(61--80)Mean follow-up time in days9621,3931,1641,9231,113(Range)(0--4,046)(735--4,046)(760--1,956)(1,229--4,046)(735--1,539)Mean lesion size in mm A × B\*37 × 3037 × 3039 × 3334 × 2736 × 28(Range)(6--98) × (6--81)(13--77) × (8--73)(13--77) × (10--73)(13--77) × (8--63)(17--75) × (11--60)Lesion changes in size36/8/024/8/012/5/09/1/03/2/0Stable/increase/decreaseNumber of septa (0/\<5/5-9/\>9)30/9/2/319/8/2/310/5/0/27/1//2/02/2/0/1Septal appearance (none/thin/thickened)30/5/919/5/810/2/57/2/12/1/2Calcification (None/minimal/mild/moderate/massive)21/4/10/9/012/4/8/8/06/1/6/4/03/3/1/3/03/0/1/1/0Lesion interface with kidney parenchyma (sharp/indistinct)42/230/217/010/03/2Contrast enhancement (none/enhancement/maybe)36/0/824/0/815/0/28/0/21/0/4\*Lesion size was measured in two dimensions on the axial imageFig. 5Transversal **a** non-contrast, **b** corticomedullary phase and **c** nephrographic phase CT image of a 66-year-old female with a moderately complex renal cystic lesion (*arrow*) showing few septa without measurable contrast enhancement (*arrowhead*), interpreted as BIIF. During the last 3-year follow-up, the lesion progressed in size but not in complexity. Note the small hemangioma in the liverFig 6Transversal **a** non-contrast, **b** corticomedullary phase and **c** nephrographic phase CT image of a 70-year-old female with an indeterminate complex renal cystic mass (*arrow*) showing multiple septa with calcification and a suspicious nodular area without measurable contrast enhancement. The arrowheads show one example of such a suspicious area. The lesion was interpreted as BIIF but very close to a BIII and has been stable for the first 2 years of follow-upFig 7Transversal **a** non-contrast, **b** corticomedullary phase and **c** coronal nephrographic phase CT image of a 69-year-old female with a moderately complex renal cystic mass (*arrow*) showing the wall and some septa containing thick and nodular calcification (*arrowhead*). The lesion was interpreted as BIIF; no progression was seen after 4 years of follow-upFig. 8Baseline transversal **a** non-contrast, **b** corticomedullary phase and **c** nephrographic phase CT image of a 64-year-old female with an indeterminate complex renal cystic mass (*arrow*) showing multiple septa with calcification and some slightly thickened septa with perceived enhancement (*arrowhead*). The lesion was interpreted as BIIF and has been stable for the first 3 years with MRI follow-up (not shown)Fig 9Transversal **a** non-contrast, **b** corticomedullary phase and **c** nephrographic phase CT image of a 85-year-old male with a typical benign BII exofytic hyperdense cyst (*arrow*) measuring 35 HU in all phasesFig 10CT images of an 85-year-old male with a large renal cell tumour on the right side (not shown) and a left-sided indeterminate complex renal cyst with thickened enhancing wall, categorised as BIII. The patient underwent right-sided nephrectomy and percutaneous cryoablation on the left side. Transversal corticomedullary phase CT images of (**a**) baseline and (**b**) 3 month after right-sided nephrectomy. The BIII lesion (*arrow*) is almost solid after 3 months, indicating aggressive behaviour. No progression was seen at 6-month follow-up imaging after percutaneous cryoablation (**c**)

Discussion {#Sec5}
==========

Classification and treatment of complex renal cysts represent a clinical challenge, demanding close cooperation between urologists and uroradiologists. Bosniak revised the original classification system of renal cysts in 1993 to include a subset of category II lesions, category IIF cysts \[[@CR5], [@CR6], [@CR14]\]. This category represents more complex cystic lesions, which cannot unequivocally be classified as category II or III. According to Bosniak, these cysts are potentially malignant and should be followed with CT examinations, performed to determine whether the cystic lesions change over time with regard to morphology and contrast enhancement pattern, subsequently resulting in an up- or downgrading \[[@CR6], [@CR9], [@CR15], [@CR16]\]. Category IIF moderately complex renal cysts may contain increased numbers of thin septa or a slightly thickened but smooth septum/septa or wall. They may also contain calcifications that may be thick and nodular, but without contrast-enhancing elements. Completely intrarenal high-attenuation cysts ≥3 cm also belong to this group.

Cystic lesions in the kidney may have a variety of different aetiologies \[[@CR2]\]. Most malignant complex renal cysts are cystic renal cell carcinomas (CRCC). Like the multilocular cystic renal cell carcinoma (MCRCC), CRCC has a very good prognosis. They are slow growing and have a low metastatic potential \[[@CR7], [@CR17]--[@CR20]\]. Due to benign changes with solid components like in mixed epithelial and stromal tumours (MEST), there will always be some benign lesions among the categories BIIF and above. These lesions are very rare, however \[[@CR21]\]. Therefore, nephron-sparing surgery is proposed when MCRCC is suspected by preoperative radiologic criteria.

The Bosniak classification consists of a number of different entities including septa characteristics and enhancement, potentially resulting in differences of interpretation among readers \[[@CR1]--[@CR3]\]. In order to validate the classification system further, studies regarding intra- and interobserver variation after the introduction of the updated version of the Bosniak classification are warranted. The best results are probably seen when radiologists are categorising complex renal cysts in plenum, as in our study \[[@CR1], [@CR2], [@CR4], [@CR12], [@CR22]\].

Bosniak classification and clinical outcome {#Sec6}
===========================================

Moderately and more complex renal cysts of category BIIF and above are quite rare, and consequently data with corresponding pathological findings are sparse. When BIIF lesions progress in terms of enhancement, changes in internal architecture by developing irregular, thick enhancing septa, solid components or multilocular characteristics, they are upgraded, and interventions are recommended. Published series with more than 20 complex renal cysts with pathological findings are presented in Table [2](#Tab2){ref-type="table"}. In the BIIF group, the 12 % malignancy rate represents BIIF lesions with radiological progression in complexity over time and subsequent upgrading. Compared to the distribution of malignancy in each Bosniak category in publications before the introduction of BIIF, the accuracy of predicting malignancy in BIII lesions has improved from 51 % to 61 % after the introduction of BIIF, which means that by introducing this category approximately 10 % could be spared surgical intervention. Surprisingly, the malignancy rate in the BII category is still unacceptably high (12 %), even in the series published after the introduction of BIIF.Table 2Published series with more than 20 complex renal cysts with pathological findingsReferencesModalityBIBIIBIIFBIIIBIVTotalBefore introduction of BIIFBrown et al. (1989) \[[@CR23]\]CT0/20/4--3/124/624Aronson et al. (1991) \[[@CR24]\]CT--0/4--5/97/720Wilson et al. (1996) \[[@CR25]\]CT0/74/5--4/46/622Cloix et al. (1996) \[[@CR17]\]CT1/21/7--4/137/1032Siegel et al. (1997) \[[@CR3]\]CT0/221/8--5/1126/2970Bielsa et al. (1999) \[[@CR26]\]CT--1/8--7/93/320Koga et al. (2000) \[[@CR19]\]CT0/111/2--10/1012/1235Curry et al. (2000) \[[@CR27]\]CT0/40/11--29/4918/1882Limb et al. (2002) \[[@CR28]\]CT--3/28--8/29--57Overall number1/4811/77--75/14683/91362Malignant vs. benignIncidence of malignancy (%)2 %14 %--51 %91 %ReferencesModalityBIBIIBIIF^\#^BIIIBIVTotalAfter introduction of BIIFIsreal et al. (2003) \[[@CR29]\]CT------9/2116/1637Isreal et al. (2003) \[[@CR6]\]CT----7/42----42Harisinghani et al. (2003) \[[@CR30]\]CT------17/28--28Isreal et al. (2004) \[[@CR31]\]CT and MRI------14/146/620Spaliviero et al. (2005) \[[@CR7]\]CT2/91/46/1219/2146Quaia et al. (2008) \[[@CR8]\]CT and CEUS--0/30/65/1318/1840O'Malley (2009) \[[@CR9]\]CT----5/7427/33107Gahr et al. (2009)\* \[[@CR10]\]CT----7/50----50Song et al. (2009) \[[@CR11]\]CT--3/260/321/3832/37104Peng et al. (2010) \[[@CR4]\]CT and CEUS0/20/3--5/612/1324Kim et al. (2010) \[[@CR12]\]CT0/343/223/1019/2628/33125Weibl et al. (2011) \[[@CR22]\]CT and MRI--0/22/315/2730/3971Pinheiro et al. (2011) \[[@CR20]\]CT5/1519/2237You et al. (2011) \[[@CR32]\]CT------22/3931/3675Our studyCT----2/38----38Overall number0/368/6527/230165/272211/241844Malignant vs. benignIncidence of malignancy (%)0 %12 %12 %61 %88 %\*BII and BIIF lesions were pooled^\#^BIIF cysts that progressed and histologically were verified as malignant

We found 44 BIIF moderately complex renal cysts among 8,402 CT examinations of the kidneys in a 7-year period. During the follow-up 16 % (5/32) of the lesions progressed radiologically, which corresponds well with the literature (Table [2](#Tab2){ref-type="table"}). Unfortunately, we do not have histological specimens of all five BIIF lesions that progressed radiologically because of co-morbidity of the patients. Two of three BIIF lesions with proven histology were malignant, indicating that radiological progression is indicative of malignancy. On the other hand, the two patients for whom histology was not available did not progress further radiologically during a mean follow-up of more than 3 years, suggesting that these lesions are either benign or low-grade aggressive.

Imaging {#Sec7}
=======

Several studies report that the chance of malignancy increases to 40--80 % when enhancement is observed within a renal cystic lesion \[[@CR5], [@CR10], [@CR12], [@CR17], [@CR23]\]. It is therefore of upmost importance that categorisation of complex cystic changes in the kidney is performed with high-quality CT in several phases. To detect enhancement in small areas such as a septum or the wall of a cyst, one cannot rely on split bolus CT examinations that present both corticomedullary and excretory phases in one examination. RCCs are often hypervascular and therefore have a characteristic contrast enhancement pattern characterised by washout in the venous phase \[[@CR33]\]. Usually protocols for characterising complex renal cysts consist of a CT without contrast (non-contrast CT, NCCT) and a minimum of two CT single-bolus phases with contrast-enhanced CT and CCT in an arterial and venous phase, respectively \[[@CR2], [@CR5]\]. Most radiologists would agree that pre- and post-contrast CT examinations are mandatory, but the number of post-contrast phases is debatable.

In most centres a multidetector CT (MDCT) is available with the possibility of performing isotropic multiplanar reconstruction in high quality. Technically, there are different software opportunities for CT---including software algorithms---to help assess iodine content in a lesion or dual-energy modes to gain additional/alternative information regarding complex renal cystic masses. Preliminary data are available in the literature regarding these issues \[[@CR34], [@CR35]\] but further studies are needed.

It is estimated that the risk of getting a fatal cancer from the ionised radiation of CT scans is approximately 1/1,000 for every 10 mSv received, assuming an effective dose of 10 mSv per scan and a risk of 5 % per Sievert \[[@CR36]\]. One study suggests that 2 % of all future cancers may be due to radiation exposure from CT examinations \[[@CR37]\]. This statement has been widely criticised and the numbers are probably lower \[[@CR38], [@CR39]\]. Depending on patient size and body habitus, radiation doses from CT are often quite high---in the range of and even above 20--30 mSv in case of 64-channel CT scanners. In our study the mean radiation dose was 12.8 mSv (7--30 mSv) on our four-channel CT. It is very important to perform radiological imaging according to the ALARA principle. This means that patients, regardless of age and disease, should be examined selectively with radiation doses "as low as reasonably achievably" according to the clinical problem in question. The Bosniak classification was initially developed solely on the basis of CT findings \[[@CR1], [@CR2]\]. Subsequently, a few studies have suggested that MR \[[@CR31], [@CR40]\] and CEUS \[[@CR4], [@CR8], [@CR41]--[@CR46]\] may be equally useful for characterisation of complex renal cystic masses. Results from these studies are promising. However, both MR \[[@CR31]\] and CEUS \[[@CR8], [@CR45], [@CR46]\] have a tendency to upgrade lesions, probably because of the superior contrast resolution compared to CT. The literature is still unequivocal on whether the higher contrast resolution of MR and CEUS will result in earlier detection of potential malignant lesions or inappropriate higher false-positive rates. Further research regarding the role of MR and CEUS are needed and forthcoming.

Follow-up imaging for BIIF lesions {#Sec8}
==================================

Recommended follow-up protocols for BIIF cystic lesions vary in the literature. To detect potential progression, a multiphase contrast CT is needed. M.A. Bosniak proposed the first control CT to be done after half a year, and if the lesion was unchanged, a control CT should be repeated annually for a minimum of 5 years \[[@CR6]\]. Other authors recommend close monitoring in the first year with CT scans after 3, 6 and 12 months. At our institution patients with complex Bosniak IIF cysts used to be followed according to the latter protocol and in cases without progression annually for 5 years. It should, however, be noted that very narrow follow-up periods may reduce detection rates if the changes in the cysts from examination to examination are very small. As a consequence of these considerations and the results of this study, we have dropped the early 3-month follow-up. However, due to the lack of prospective series, the most appropriate follow-up regimen in these patients is still debatable \[[@CR9]\].

Bosniak IIF lesions vary in appearance: (1) BIIF lesions with minimal findings close to category II in complexity and (2) BIIF lesions that are closer to category III in complexity. M.A. Bosniak has recently suggested that BIIF cysts with minimal findings only need follow-up for 1--2-years, whereas more complex BIIF cysts should be followed for a longer period (e.g., 3--4 years or longer) \[[@CR1]\]. This seems to be a reasonable compromise taking into consideration the high, cumulated radiation dose of repeated examinations. CT is still considered the gold standard when categorising complex renal cystic masses. For BIIF lesions an early switch to MRI/CEUS with a baseline examination immediately following the CT examination is now used at many institutions. Long-term data on such a regime may change clinical management in the future. Caution must be made for lesions ≤2 cm \[[@CR1]\]. We have chosen to stop follow-up if no progression is seen after 5 years, suggesting that the BIIF lesion was benign. To our knowledge this has only been debated very sparsely in the literature, and studies on the most appropriate follow-up regimen in these patients are, as mentioned, warranted \[[@CR1], [@CR2], [@CR5], [@CR47]\].

Biopsy and minimally invasive intervention {#Sec9}
==========================================

Biopsy of moderate complex cystic masses in the kidney has recently come into focus and the trend seems to be a more aggressive approach \[[@CR2], [@CR9], [@CR15], [@CR30], [@CR48], [@CR49]\]. This is presumably to avoid follow-up imaging of those BIIF lesions that are close to BIII and undoubtedly due to the possibility of using local nephron-sparing treatment (ablation with cryo/radiofrequency therapy and/or laparoscopic resection). Whether biopsy and aspiration of the cyst fluid should be used routinely is controversial. It may be problematic to accept a negative biopsy result since the renal cysts usually are very inhomogeneous. In general, it is recommended that Bosniak category III and IV lesions be treated surgically or with minimally invasive ablation measures. The treatment strategy depends on the size and localisation of the lesion and the patient's general condition. It should be noted, however, that the indication for minimally invasive treatment in cases with suspected malignancy is still regarded as being in the exploratory phase. Routine use of these minimally invasive methods should therefore be protocolised and results published.

Although our numbers are small, the data seem to be consistent in the regard that if progression occurs radiologically, it corresponds to pathological results. The corresponding aggressiveness of the lesions needs further evaluation in prospective studies, however. Our cases were analysed in consensus, so interobserver variability could not be evaluated. Like M.A. Bosniak, we believe that, if the complexity of a category II lesion is in question, the lesion should be placed in category IIF. In cases of disagreement among the radiologists, the lesion should always be placed in the highest category \[[@CR5], [@CR13], [@CR47], [@CR50]\]. Furthermore, decisions on the intervention may be easily influenced by clinical parameters, as in our series, in which surgical resection was omitted because of co-morbidity. Other comparable studies have the same limitation with regard to accordance between radiological and pathological progression, since not all category IIF lesions that progressed were resected \[[@CR6], [@CR9], [@CR10]\].

Conclusion {#Sec10}
==========

By critically evaluating the outcome of complex renal cysts using the Bosniak classification, we found that out of 32 Bosniak category IIF lesions only 5 (16 %) were upgraded during follow-up. Malignant progression did occur in two of these lesions, and follow-up examinations are considered necessary. The introduction of Bosniak category IIF seems promising, potentially resulting in a rational and an overall nephron-sparing approach to complex renal cysts.
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